Elan developing new arthritis drug

Irish pharmaceutical giant Elan, along with partner Biogen, have filed an investigational new drug application with the US Food and Drug Administration (FDA) for a drug called Antegren.

Antegren is being developed for the treatment of rheumatoid arthritis.